Advertisement
Research Article Free access | 10.1172/JCI108761
Abteilung für Klinische Chemie und Zentrallaboratorium der Universitätskliniken Köln, 5 Köln, West Germany
Molecular Disease Branch, National Heart and Lung Institute, National Institutes of Health, Bethesda, Maryland 20014
Donner Laboratory, University of California, Berkeley, California 94720
Find articles by Assmann, G. in: JCI | PubMed | Google Scholar
Abteilung für Klinische Chemie und Zentrallaboratorium der Universitätskliniken Köln, 5 Köln, West Germany
Molecular Disease Branch, National Heart and Lung Institute, National Institutes of Health, Bethesda, Maryland 20014
Donner Laboratory, University of California, Berkeley, California 94720
Find articles by Herbert, P. in: JCI | PubMed | Google Scholar
Abteilung für Klinische Chemie und Zentrallaboratorium der Universitätskliniken Köln, 5 Köln, West Germany
Molecular Disease Branch, National Heart and Lung Institute, National Institutes of Health, Bethesda, Maryland 20014
Donner Laboratory, University of California, Berkeley, California 94720
Find articles by Fredrickson, D. in: JCI | PubMed | Google Scholar
Abteilung für Klinische Chemie und Zentrallaboratorium der Universitätskliniken Köln, 5 Köln, West Germany
Molecular Disease Branch, National Heart and Lung Institute, National Institutes of Health, Bethesda, Maryland 20014
Donner Laboratory, University of California, Berkeley, California 94720
Find articles by Forte, T. in: JCI | PubMed | Google Scholar
Published July 1, 1977 - More info
The nature of the high density lipoproteins has been investigated in five patients homozygous for Tangier disease (familial high density lipoprotein deficiency). It has been established that Tangier high density lipoproteins, as isolated by ultracentrifugation, are morphologically heterogenous and contain several proteins (Apo B, albumin, and Apo A-II). An abnormal lipoprotein has been isolated from the d = 1.063-1.21 g/ml ultracentrifugal fraction by agarose-column chromatography which contains apoprotein A-II as the sole protein constituent. In negative-stain electron microscopy, these lipoproteins appeared as spherical particles 55-75 Å in diameter. By a variety of criteria (immunochemical, polyacrylamide electrophoresis, amino acid composition, and fluorescence measurements), apoprotein A-I the major apoprotein of normal high density lipoproteins and the C apoproteins were absent from this lipoprotein. As demonstrated by 125I very low density lipoprotein incubation experiments with Tangier plasma, C apoproteins did not associate with lipoproteins of d = 1.063-1.21 g/ml. Tangier apoprotein A-II, isolated to homogeneity by delipidation of the apoprotein A-II-containing lipoprotein or Sephadex G-200 guanidine-HCl chromatography of the d = 1.063-1.21 g/ml fraction, was indistinguishable from control apoprotein A-II with respect to amino acid composition and migration of tryptic peptides in urea-polyacrylamide electrophoresis. The ability of Tangier apoprotein A-II to bind phospholipid was demonstrated by in vitro reconstitution experiments and morphological and chemical analysis of lipid-protein complexes.
It is concluded that normal high density lipoproteins, as defined by polypeptide composition and morphological appearance, are absent from Tangier plasma and that as a consequence, the impairment of C apoprotein metabolism contributes to the hypertriglyceridemia and fasting chylomicronemia observed in these patients.
Images.